Wockhardt Limited will hold its 27th Annual General Meeting (AGM) on Monday, August 10, 2026, at 3:30 p.m. IST through Video Conferencing (VC) or Other Audio Visual Means (OAVM). The meeting will transact business as set out in the notice dated May 4, 2026. The company has fixed Wednesday, August 5, 2026, as the record date to determine the entitlement of members to vote at the AGM and participate in remote e-voting.

The Notice of the 27th AGM and the Annual Report for FY 2026 have been dispatched to shareholders whose email addresses are registered with the company or its Registrar and Share Transfer Agent. These documents are also available on the company's website and the websites of BSE Limited and National Stock Exchange of India Limited.

E-Voting Schedule

Pursuant to the provisions of Section 108 of the Companies Act, 2013, and Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company has provided a remote e-voting facility. Shareholders whose names are recorded in the Register of Members or in the Register of Beneficial Owners as on the cut-off date of August 5, 2026, are entitled to vote.

The remote e-voting module will be disabled immediately after the end date. Members who cast their vote via remote e-voting prior to the AGM may attend the meeting through VC/OAVM but will not be entitled to vote again during the AGM.

Meeting Participation

Shareholders who acquire shares and become members of the company after the dispatch of the AGM notice but hold shares as of the cut-off date may obtain their login ID and password by sending a request to the designated email address. Those already registered for e-voting can use their existing user credentials. Detailed procedures for remote e-voting and participation through VC/OAVM are outlined in the Notice of the 27th AGM.

Wockhardt Limited has announced the convening of its 27th Annual General Meeting (AGM) on Monday, August 10, 2026, at 3:30 p.m. (IST), to be held through Video Conferencing (VC)/Other Audio Visual Means (OAVM). The notice, issued pursuant to Regulations 29, 30 and 34(1) of the SEBI Listing Regulations, was filed by Company Secretary Rashmi Mamtura on July 17, 2026. The AGM shall be deemed to be held at the Registered Office of the Company at D-4 MIDC, Chikalthana, Chhatrapati Sambhajinagar – 431 006.

Key AGM Agenda Items

The meeting will transact both ordinary and special business. The ordinary business includes adoption of audited standalone and consolidated financial statements for the financial year ended March 31, 2026, and the re-appointment of Ms. Zahabiya Khorakiwala (DIN: 00102689), who retires by rotation and offers herself for re-appointment.

The following table summarises the key resolutions proposed at the 27th AGM:

Executive Remuneration Revision

The Board of Directors and the Nomination and Remuneration Committee, at their respective meetings held on May 4, 2026, proposed a revision in remuneration payable to Dr. Habil Khorakiwala, Executive Chairman, for the remaining three years of his tenure from March 1, 2027 to February 28, 2030. The revised remuneration will be ₹10 Crore per annum for the period commencing from March 1, 2027 till February 29, 2028, which may be further revised from time to time till February 28, 2030, subject to an overall ceiling of ₹15 Crore per annum. Dr. Habil Khorakiwala was originally appointed as Executive Chairman for a term of five years at the Twenty-Fifth AGM held on June 28, 2024.

Capital Raising and QIP Proceeds Redeployment

The company seeks enabling approval to issue securities for a value not exceeding ₹3,000 Crore (Rupees Three Thousand Crore Only) or its equivalent in any foreign currency, through one or more public and/or private offerings including a Qualified Institutions Placement (QIP). The proceeds may be utilised for business purposes including capital expenditure, research and development, repayment/prepayment of long-term and short-term debt, and general corporate purposes.

Separately, shareholders will vote on the redeployment of unutilised QIP proceeds from the November 11, 2024 placement. The following table details the original use of proceeds and the current utilisation status as of March 31, 2026:

The company proposes to redeploy the unutilised balance of approximately ₹162.33 Crore towards funding capital expenditure and investment in targeted R&D activities encompassing Biosimilar, New Chemical Entities (NCE) and other products. The Board of Directors has also extended the timeline for utilisation of such funds from financial year 2026 up to financial year 2028.

Material Related Party Transactions

The company seeks member approval for material related party transactions with three subsidiaries. Transactions with Wockhardt Bio AG — a subsidiary in which Wockhardt holds 85.85% — include sale of goods, recovery of management and technical fees, and transfer of Intellectual Property Rights, with an aggregate value up to ₹1,000 Crore. During FY 2025-26, transactions with Wockhardt Bio AG aggregated to ₹584.33 Crore. Proposed transactions between Wockhardt Bio AG and CP Pharmaceuticals Limited (a step-down subsidiary) and between Wockhardt Bio AG and Wockhardt UK Limited are each capped at ₹550 Crore.

Ms. Zahabiya Khorakiwala's Appointment at Wockhardt Bio AG

The Board approved the appointment of Ms. Zahabiya Khorakiwala as Executive Co-chairperson of Wockhardt Bio AG with effect from May 4, 2026, at a remuneration of USD 250,000 per annum, together with such benefits and reimbursements as may be approved in accordance with applicable policies. Her responsibilities will include market access strategy, stakeholder engagement, and partnership development for the company's Global NCE portfolio with a focus on the United States and allied markets.

E-Voting and AGM Schedule

Key dates for the AGM process are as follows:

E-voting services are being provided by NSDL. Mr. Virendra Bhatt, Practicing Company Secretary (ACS No. 1157, CP No. 124/Peer Review Certificate No. 6489/2025), has been appointed as Scrutinizer for the remote e-voting process.

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE049B01025/1aaad7bf-1ec6-4ac2-97dc-2c8a6234d2b3.pdf